Navigation Links
Stanford's Hank Greely puts neuroscience on trial
Date:2/20/2010

A lawyer is trying to convince a jury that his client really is crazy. It's usually a tough argument to sell in a court of law. But what if the lawyer has a picture of his client's brain that shows there's something biologically wrong with it? Can that evidence help persuade a jury? Should it even be allowed as evidence?

Those are some of the questions that will be addressed during a presentation and mock trial scheduled from 8:30 to 11:30 a.m. Feb. 20 at the annual meeting of the American Association for the Advancement of Science (AAAS) in San Diego.

Hank Greely, a Stanford law professor and expert on the legal, ethical and social issues surrounding the biosciences, will take on the role of prosecutor during a presentation titled "The Brain on Trial: Neuroscience Evidence in the Courtroom."

"The prosecutor's typical position is that brain scan evidence shouldn't be used because they say it's not scientifically useful," Greely said. "They say it will confuse the jury, that it's not relevant, that the technology isn't good enough yet. But most of all, they'll say that's fine that you found this person has an abnormal brain but how many other people have similar abnormalities and don't commit crimes? The answer will be: quite a few."

With no hard-and-fast rules on whether neuroscience evidence should be allowed in state and federal courts, Greely is studying criminal cases in California that have featured brain scan images to help prove guilt or maintain innocence.

He's so far found that defense attorneys are more likely than prosecutors to try using neuroscience evidence, but he cautions that the tool is a double-edged sword.

While an MRI result showing a deformed or malfunctioning brain could conjure empathy and a finding of innocence, it could also lead jurors and judges to opt for convictions and long sentences based on the assumption that such a damaged mind will only convince the person using it to offend again.

"Neuroscience evidence will probably mostly be used alongside behavioral evidence," Greely said. "There will always be behavioral evidence to show a defendant was crazy as a loon. Neuroscience will be able to further hammer home the idea that the person truly has a problem."


'/>"/>

Contact: Adam Gorlick
agorlick@stanford.edu
650-725-0224
Stanford University
Source:Eurekalert

Related biology news :

1. European Research Council grant for neuroscience research
2. Elseviers BrainNavigator research tool to launch new features at Neuroscience 2009 show
3. NTU, University of Warwick to collaborate in neuroscience research
4. Neuroinformatics special issue spotlights the Neuroscience Information Framework
5. Penn announces $50M Penn Integrates Knowledge neurosciences initiative
6. Stroke and SIDS in Alaska topics of neuroscience conference
7. Society for Neuroscience 38th Annual Meeting
8. News tips from the Journal of Neuroscience
9. Brains R Us: Neuroscience and education town hall
10. Shigetada Nakanishi receives $500,000 Gruber Neuroscience Prize
11. NARSAD presents 2007 prizes for outstanding achievement in neuroscience and psychiatric research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
Breaking Biology Technology: